Payment overview · 2025
General Payments
$107.95
2 reported records · 2 companies
Healthcare provider profile · identity verified
William Warren Blymire, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BUFFALO, NY · NPI 1306095468
Verified facts
What the public records show
CMS Open Payments records show William Warren Blymire, MD received $107.95 in general payments during 2025 across 2 reported records.
Soleno Therapeutics, Inc. accounted for 87.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Soleno Therapeutics, Inc. | Unresolved — no canonical attribution shown | $94.15 | 87.2% | 1 | 2025 |
| Biogen, Inc. | Unresolved — no canonical attribution shown | $13.80 | 12.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $107.95 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VYKAT XR Normalized: vykat xr |
Drug | Soleno Therapeutics, Inc. | $94.15 | 1 | 2025 |
Source payment records
|
|||||
| SKYCLARYS Normalized: skyclarys |
Drug | Biogen, Inc. | $13.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 642 | 89 |
| Lisinopril | Lisinopril | 460 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 397 | 56 |
| Omeprazole | Omeprazole | 390 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 342 | 48 |
| Metformin Hcl | Metformin Hcl | 249 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 243 | 53 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 173 | 28 |
| Gabapentin | Gabapentin | 157 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 18 |
| Simvastatin | Simvastatin | 144 | 19 |
| Losartan Potassium | Losartan Potassium | 143 | 19 |
| Alendronate Sodium | Alendronate Sodium | 129 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 129 | 21 |
| Lactulose | Lactulose | 119 | 16 |
| Trulicity | Dulaglutide | 111 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 102 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 100 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 97 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 94 | 28 |
| Sertraline Hcl | Sertraline Hcl | 89 | 14 |
| Famotidine | Famotidine | 86 | 14 |
| Furosemide | Furosemide | 84 | 14 |
| Eliquis | Apixaban | 78 | 12 |
| Trazodone Hcl | Trazodone Hcl | 76 | 11 |
| Jardiance | Empagliflozin | 75 | 11 |
| Pregabalin | Pregabalin | 75 | suppressed |
| Levetiracetam | Levetiracetam | 68 | suppressed |
| Ibuprofen | Ibuprofen | 64 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 63 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 60 | suppressed |
| Linzess | Linaclotide | 59 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 57 | suppressed |
| Januvia | Sitagliptin Phosphate | 55 | suppressed |
| Carvedilol | Carvedilol | 52 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 50 | suppressed |
| Potassium Chloride | Potassium Chloride | 49 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 48 | suppressed |
| Baclofen | Baclofen | 48 | suppressed |
| Clonazepam | Clonazepam | 47 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 47 | suppressed |
| Allopurinol | Allopurinol | 46 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 45 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 41 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 41 | suppressed |
| Spironolactone | Spironolactone | 41 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 40 | suppressed |
| Vascepa | Icosapent Ethyl | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | suppressed |
| Diazepam | Diazepam | 38 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 33 | suppressed |
| Finasteride | Finasteride | 32 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 32 | suppressed |
| Lovastatin | Lovastatin | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 31 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Lorazepam | Lorazepam | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 27 | suppressed |
| Prednisone | Prednisone | 27 | 11 |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 26 | suppressed |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Bumetanide | Bumetanide | 25 | suppressed |
| Gemtesa | Vibegron | 25 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 24 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Nystatin | Nystatin | 23 | suppressed |
| Ozempic | Semaglutide | 23 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 22 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 21 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Invokana | Canagliflozin | 20 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 20 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Risperidone | Risperidone | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Meloxicam | Meloxicam | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Blisovi Fe | Norethindrone-E.Estradiol-Iron | 13 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Norethindrone | Norethindrone | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 12 | suppressed |
| Famciclovir | Famciclovir | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Cabergoline | Cabergoline | 11 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Trileptal | Oxcarbazepine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $107.95 · 2 records | Soleno Therapeutics, Inc. | SKYCLARYS, VYKAT XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error